Drug recall
Red Blood Cells
FDA recall event 29039 · Class III · NIH/Warren Grant Magnuson Clinical Center
Key facts
| Event ID | 29039 |
|---|---|
| Recall numbers | B-1899-4, B-1900-4 |
| Recalling firm | NIH/Warren Grant Magnuson Clinical Center |
| Product type | Biologics |
| Products | Red Blood Cells, Red Blood Cells, Deglycerolized |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, incorrectly tested for Hepaitis B surface antigen (HBsAg) and for the antibody to Hepatitis B core antigen (anti-HBc), were distributed. |
| Initiation date | Feb 10, 2004 |
| Termination date | Sep 24, 2004 |
| City | Bethesda |
| Country | United States |
| FEI number | 1174694 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports